Literature DB >> 15673393

QT correction methods in children and adolescents.

Joachim F Wernicke1, Douglas Faries, Rebecca Breitung, Donald Girod.   

Abstract

INTRODUCTION: Accurate determination of the QTc interval has become increasingly important in the assessment of a drug's ability to prolong cardiac repolarization. Previous work suggests the most appropriate correction formula for adults is QTc=QT/RR0.40, but little on correction methods for children and adolescents has been published. METHODS AND
RESULTS: In this study, ECG data were obtained from a meta-analysis of seven clinical trials for attention deficit/hyperactivity disorder (ADHD) involving 2,288 children and adolescents. The most appropriate formula for children and adolescents included in this database was found to be QTc=QT/RR0.38. Adjustments of the correction factor specifically for males and females of different ages also are reported.
CONCLUSION: QT correction methods developed for adults do not apply to children. As accurate QTc determination plays a larger role in assessing a drug's potential to retard repolarization, use of age- and gender-specific correction formulas becomes more important.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673393     DOI: 10.1046/j.1540-8167.2005.03520.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

1.  Comparison of formulas for calculation of the corrected QT interval in infants and young children.

Authors:  Derek Q Phan; Michael J Silka; Yueh-Tze Lan; Ruey-Kang R Chang
Journal:  J Pediatr       Date:  2015-01-31       Impact factor: 4.406

2.  Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.

Authors:  Sabrina A Poole; Anna Pecoraro; Geetha Subramaniam; George Woody; Victoria L Vetter
Journal:  J Addict Med       Date:  2016 Jan-Feb       Impact factor: 3.702

3.  Population pharmacokinetic/pharmacodynamic modeling of guanfacine effects on QTc and heart rate in pediatric patients.

Authors:  William Knebel; James Ermer; Jaideep Purkayastha; Patrick Martin; Marc R Gastonguay
Journal:  AAPS J       Date:  2014-08-19       Impact factor: 4.009

4.  Droperidol transiently prolongs the QT interval in children undergoing single ventricle palliation.

Authors:  John P Scott; Eckehard A E Stuth; Astrid G Stucke; Joseph R Cava; Richard J Berens
Journal:  Pediatr Cardiol       Date:  2014-08-03       Impact factor: 1.655

5.  Effect of dexmedetomidine on the QT interval in pediatric patients undergoing general anesthesia.

Authors:  Hiromi Kako; Senthil G Krishna; Roby Sebastian; Kyle Smith; Joseph D Tobias
Journal:  J Anesth       Date:  2015-08-04       Impact factor: 2.078

6.  QT correction methods in infants and children: effects of age and gender.

Authors:  Abraham Benatar; Arjen Feenstra
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-09       Impact factor: 1.468

7.  High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children.

Authors:  Johan Ursing; Lars Rombo; Staffan Eksborg; Lena Larson; Anita Bruvoll; Joel Tarning; Amabelia Rodrigues; Poul-Erik Kofoed
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

8.  European guidelines on managing adverse effects of medication for ADHD.

Authors:  J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-03       Impact factor: 4.785

9.  Methods of assessment and clinical relevance of QT dynamics.

Authors:  Beata Sredniawa; Agata Musialik-Lydka; Piotr Jarski; Anna Sliwinska; Zbigniew Kalarus
Journal:  Indian Pacing Electrophysiol J       Date:  2005-07-01

10.  Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.

Authors:  George O Adjei; Collins Oduro-Boatey; Onike P Rodrigues; Lotte C Hoegberg; Michael Alifrangis; Jorgen A Kurtzhals; Bamenla Q Goka
Journal:  Malar J       Date:  2012-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.